HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosemarie Reiter Selected Research

Glycoproteins (Glycoprotein)

3/2005Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosemarie Reiter Research Topics

Disease

4Inflammation (Inflammations)
09/2004 - 10/2002
2Endotoxemia
11/2003 - 09/2003
1Unstable Angina
03/2005
1Hemorrhage
03/2005
1Atherosclerosis
09/2004
1Hypercholesterolemia
09/2004
1Sepsis (Septicemia)
09/2003
1Acute Coronary Syndrome
10/2002
1Thrombocytopenia (Thrombopenia)
10/2002

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
03/2005 - 09/2003
2ThrombinFDA Link
11/2003 - 09/2003
1Glycoproteins (Glycoprotein)IBA
03/2005
1Platelet Membrane Glycoprotein IIbIBA
03/2005
1EnalaprilFDA LinkGeneric
09/2004
1Angiotensin Receptors (Angiotensin II Receptor)IBA
09/2004
1Biomarkers (Surrogate Marker)IBA
09/2004
1Angiotensin Receptor AntagonistsIBA
09/2004
1Losartan (Cozaar)FDA LinkGeneric
09/2004
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2004
1Angiotensin IIIBA
09/2004
1PAR-1 ReceptorIBA
11/2003
1thrombin receptor peptide SFLLRNPIBA
11/2003
1EndotoxinsIBA
11/2003
1AnticoagulantsIBA
09/2003
1drotrecogin alfa activated (Xigris)FDA Link
09/2003
1Protein CIBA
09/2003
1Messenger RNA (mRNA)IBA
09/2003
1fibrin fragment D (D-dimer)IBA
09/2003
1HirudinsIBA
10/2002
1Heparin (Liquaemin)FDA LinkGeneric
10/2002
1lepirudin (Refludan)FDA Link
10/2002

Therapy/Procedure

1Percutaneous Coronary Intervention
03/2005
1Aftercare (After-Treatment)
09/2004
1Therapeutics
10/2002